-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Olin reported a net loss of $83.0M, or -$0.73 per share vs. net income of $1.4M, or $0.01 per share, in Q1 2025, with sales declining 3.7% to $1,583.0M and adjusted EBITDA falling to $86.2M from $185.6M. The Chlor Alkali segment posted a $44.5M loss vs. $78.3M earnings due to lower pricing/volumes and higher costs, while Winchester sales rose 21.3% to $470.5M, though segment earnings declined. We believe the company is navigating challenging market conditions through its Beyond250 cost reduction program and sequential EBITDA improvement from Q4 2025. Management provided Q2 2026 adjusted EBITDA guidance of $160M-$200M, reflecting expected sequential improvement from seasonally higher demand and pricing gains. We expect the Iran conflict to benefit North American operations through supply disruptions, while net debt/EBITDA increased to 5.1x from 3.5x, though the company maintained $1.3B liquidity and declared its 398th consecutive quarterly dividend of $0.20 per share.